Adipose tissue is highly specialized, and plays important roles in glucose homeostasis, lipid synthesis and metabolism, and energy storage. 1, 2j More recently, the role of adipose tissue as a passive storage depot has changed to that of a true endocrine organ. Several fold) from patients with Type 2 diabetes (Fig. 1) .
Sequencing #1738 and subsequent BLAST analysis revealed that this clone was identical to a recently cloned adipose-specific gene apM1. [10] Consistent with earlier reports on the murine orthologue Acrp30/AdipoQ, [8, 9] apM1 mRNA was readily detectable in mature human adipocytes but not in preadipocytes (Fig. 2) . These data verify that apM1 is expressed in human adipocytes.
To confirm our findings from colony arrays, expression of apM1 was analyzed by semiquantitative RT-PCR. Consistent with our previous data, expression of apM1 was reduced 4.8 fold in the omental adipose tissue of Type 2 diabetic patients (normalized apM1=0.39+0.17)compared to the non-diabetic obese subjects (normalized apM1 1.91 4-0.19) used to generate the subtracted library (Fig. 3A) (Fig. 3B) . In order to determine whether abnormalities in apM1 expression exist in other adipose depots, we analyzed apM1 in subcutaneous adipose tissue. As can be seen in Figure 3C , apM1 was reduced 2 Recently, a Japanese study reported that plasma levels of apM1 were negatively correlated with BMI. I121 Interestingly, the correlation between BMI and apM1 was stronger in male (r=-0.71) compared to female (r=-0.51) subjects. Moreover, apM1 levels were significantly higher in women compared to men, independent of adiposity. In this regard circulating apM1 is similar to leptin, which is also elevated in women compared to men per unit of fat mass. [14] These data suggest that gender-based differences exist in the regulation of apM1 gene expression.
In the patients used in the present study, we were unable to detect a significant change in apM1 expression in either omental or subcutaneous adipose tissue associated with obesity in the absence of frank diabetes. These findings contrast with an earlier study 91 that reported a reduction in apM1 mRNA in obese humans. Since the previous study employed a more accurate Northern blot analysis, one might speculate that the disparity in results was generated by our use of RT-PCR. However, we found that leptin mRNA levels were elevated 4-6 fold with obesity in our patients using RT-PCR under identical conditions (data not shown), validating our technique with data from previous studies.
[ 15' 161 A more likely source for the disparity in findings is the small number of patients used in this and previous 9 studies. Moreover, our patients were women, which exhibit greater variability in apM1 levels in comparison with men. [12] [ In addition, the chromosomal location of the apM1 gene is in a susceptibility locus for Familial Combined Hyperlipidaemia and polygenic Type 2 diabetes. [13] Based on these data, an intriguing consideration is that reduced apM1 levels somehow participate in the development of Type 2 diabetes. As the function and signaling properties of apM1 are presently unknown, future studies will be necessary to determine its role in the pathophysiology of obesity and Type 2 diabetes.
